Nurix Therapeutics, Inc. (NRIX)

26.27 -0.45 (-1.68%) USD  |  NASDAQ  |  Aug 24, 16:00
26.35 +0.08 (+0.30%) After-Hours: 06:27
More

Nurix Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for NRIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to 2023. Start Trial.
Date Value
November 30, 2025 --
November 30, 2024 --
Date Value
November 30, 2023 --

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Monte Rosa Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
TG Therapeutics, Inc. Upgrade
Cue Biopharma, Inc. Upgrade
Keros Therapeutics, Inc. Upgrade